Henry Schein to Present at Two Virtual Investor Conferences in September

Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of healthcare solutions, announced its participation in two investor conferences in September 2021. The company will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. ET, and the Baird 2021 Virtual Global Healthcare Conference on September 14, 2021, at 12:50 p.m. ET. Live webcasts will be available on the company's website, with replays accessible afterward. Henry Schein serves over 1 million customers globally, emphasizing operational success and clinical outcomes.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at two investor conferences in September:

• Morgan Stanley 19^th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. Eastern time
• Baird 2021 Virtual Global Healthcare Conference on September 14, 2021, at 12:50 p.m. Eastern time

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. A replay will be available on the Henry Schein website following the presentations.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 21,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental and medical laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $10.1 billion in 2020, and have grown at a compound annual rate of approximately 12 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005178/en/

Steven Paladino

Executive Vice President and CFO

steven.paladino@henryschein.com

(631) 843-5500



Investor Relations

631-390-8105

investor@henryschein.com



Media: Ann Marie Gothard

Vice President, Corporate Media Relations

annmarie.gothard@henryschein.com

(631) 390-8169

Source: Henry Schein, Inc.

FAQ

When is Henry Schein presenting at the Morgan Stanley Global Healthcare Conference?

Henry Schein will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. Eastern time.

What date does Henry Schein participate in the Baird Virtual Global Healthcare Conference?

Henry Schein will participate in the Baird 2021 Virtual Global Healthcare Conference on September 14, 2021, at 12:50 p.m. Eastern time.

How can I listen to the Henry Schein conference presentations?

The presentations can be heard via live webcast at www.henryschein.com/IRwebcasts.

What is the stock symbol for Henry Schein?

The stock symbol for Henry Schein is HSIC.

What services does Henry Schein provide?

Henry Schein provides healthcare solutions for dental and medical practitioners, emphasizing operational success and clinical outcomes.